ARCHIVES

NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case.

This article is from The Cancer Letter archive.

Vol. 27 No. 33 | September 14, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

In Brief: GM Cancer Research Foundation Awards Three Prizes to Five Cancer Researchers

May 5, 2000

Compliance Grants Awarded, Contract Pending On Differences In Black/White Survival

November 19, 1982

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011